Congress Wealth Management LLC DE trimmed its holdings in shares of STERIS plc (NYSE:STE – Free Report) by 5.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 54,145 shares of the medical equipment provider’s stock after selling 2,879 shares during the quarter. Congress Wealth Management LLC DE’s holdings in STERIS were worth $11,130,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Avalon Trust Co purchased a new stake in shares of STERIS during the 4th quarter valued at about $30,000. Human Investing LLC purchased a new stake in STERIS in the fourth quarter worth approximately $31,000. Anfield Capital Management LLC grew its position in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division raised its stake in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC lifted its holdings in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. Institutional investors own 94.69% of the company’s stock.
Wall Street Analyst Weigh In
STE has been the subject of a number of research reports. JMP Securities reiterated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reaffirmed an “overweight” rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $258.75.
STERIS Stock Up 1.2 %
NYSE STE opened at $223.03 on Tuesday. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $21.91 billion, a P/E ratio of 47.35 and a beta of 0.92. The stock’s 50-day moving average price is $221.34 and its 200-day moving average price is $221.73.
STERIS (NYSE:STE – Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current year.
STERIS Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS’s dividend payout ratio is presently 48.41%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- Transportation Stocks Investing
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What is the Dow Jones Industrial Average (DJIA)?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Business Services Stocks Investing
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.